Biomaxima SA (BMX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Synektik SA

Biomaxima SA

PZ Cormay SA

Zortrax SA

Medicalgorithmics SA

Scope Fluidics SA

Medinice SA

Airway Medix SA

Milestone Medical, Inc.

Grupa Modne Zakupy SA

Milton Essex SA

Why is Biomaxima SA ?

High Debt Company with a Debt to Equity ratio (avg) at times

High Debt Company with a Debt to Equity ratio (avg) at times

High Debt company with Weak Long Term Fundamental Strength

The company has declared Negative results for the last 8 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at PLN -2.05 MM
DEBT-EQUITY RATIO (HY) Highest at 31.25 %

With ROE of 1.49%, it has a fair valuation with a 1.14 Price to Book Value

The stock is trading at a discount compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -1.27%, its profits have risen by 115% ; the PEG ratio of the company is 0.2

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -1.27% returns in the last 1 year, the stock has also underperformed Poland WIG in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Biomaxima SA should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Biomaxima SA for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Biomaxima SA

-4.51%

-0.79

39.90%

Poland WIG

39.24%

1.84

20.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

4.88%

EBIT Growth (5y)

-40.97%

EBIT to Interest (avg)

11.03

Debt to EBITDA (avg)

2.19

Net Debt to Equity (avg)

0.28

Sales to Capital Employed (avg)

0.85

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

26.53%

ROE (avg)

24.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.14

EV to EBIT

68.60

EV to EBITDA

15.85

EV to Capital Employed

1.11

EV to Sales

1.20

PEG Ratio

0.21

Dividend Yield

ROCE (Latest)

1.25%

ROE (Latest)

1.49%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company

PRE-TAX PROFIT(Q)

At PLN 0.68 MM has Grown at 794.12%

NET PROFIT(Q)

At PLN 0.59 MM has Grown at 340.37%

INVENTORY TURNOVER RATIO(HY)

Highest at 3.99%

RAW MATERIAL COST(Y)

Fallen by -44.5% (YoY

-5What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at PLN -2.05 MM

DEBT-EQUITY RATIO (HY)

Highest at 31.25 %

Here's what is working for Biomaxima SA

Pre-Tax Profit

At PLN 0.68 MM has Grown at 794.12%

over average net sales of the previous four periods of PLN 0.08 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (PLN MM)

Net Profit

At PLN 0.59 MM has Grown at 340.37%

over average net sales of the previous four periods of PLN 0.13 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (PLN MM)

Inventory Turnover Ratio

Highest at 3.99% and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -44.5% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Biomaxima SA

Operating Cash Flow

Lowest at PLN -2.05 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (PLN MM)

Debt-Equity Ratio

Highest at 31.25 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio